Protect Pharmaceutical Stock Probability of Future Pink Sheet Price Finishing Over 0.8

PRTT Stock  USD 0.89  0.01  1.11%   
Protect Pharmaceutical's future price is the expected price of Protect Pharmaceutical instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Protect Pharmaceutical performance during a given time horizon utilizing its historical volatility. Check out Protect Pharmaceutical Backtesting, Protect Pharmaceutical Valuation, Protect Pharmaceutical Correlation, Protect Pharmaceutical Hype Analysis, Protect Pharmaceutical Volatility, Protect Pharmaceutical History as well as Protect Pharmaceutical Performance.
  
Please specify Protect Pharmaceutical's target price for which you would like Protect Pharmaceutical odds to be computed.

Protect Pharmaceutical Target Price Odds to finish over 0.8

The tendency of Protect Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 0.80  in 90 days
 0.89 90 days 0.80 
about 87.49
Based on a normal probability distribution, the odds of Protect Pharmaceutical to stay above $ 0.80  in 90 days from now is about 87.49 (This Protect Pharmaceutical probability density function shows the probability of Protect Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Protect Pharmaceutical price to stay between $ 0.80  and its current price of $0.89 at the end of the 90-day period is about 5.24 .
Given the investment horizon of 90 days the pink sheet has the beta coefficient of 1.49 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Protect Pharmaceutical will likely underperform. Additionally Protect Pharmaceutical has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Protect Pharmaceutical Price Density   
       Price  

Predictive Modules for Protect Pharmaceutical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Protect Pharmaceutical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Protect Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.040.8913.27
Details
Intrinsic
Valuation
LowRealHigh
0.040.8513.23
Details
Naive
Forecast
LowNextHigh
0.020.9413.33
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.800.951.11
Details

Protect Pharmaceutical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Protect Pharmaceutical is not an exception. The market had few large corrections towards the Protect Pharmaceutical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Protect Pharmaceutical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Protect Pharmaceutical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.91
β
Beta against Dow Jones1.49
σ
Overall volatility
0.40
Ir
Information ratio -0.07

Protect Pharmaceutical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Protect Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Protect Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Protect Pharmaceutical generated a negative expected return over the last 90 days
Protect Pharmaceutical has high historical volatility and very poor performance
Protect Pharmaceutical has some characteristics of a very speculative penny stock
Protect Pharmaceutical currently holds 101 K in liabilities. Protect Pharmaceutical has a current ratio of 0.39, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Protect Pharmaceutical until it has trouble settling it off, either with new capital or with free cash flow. So, Protect Pharmaceutical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Protect Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Protect to invest in growth at high rates of return. When we think about Protect Pharmaceutical's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (122.61 K) with profit before overhead, payroll, taxes, and interest of 0.
About 84.0% of the company outstanding shares are owned by corporate insiders

Protect Pharmaceutical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Protect Pink Sheet often depends not only on the future outlook of the current and potential Protect Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Protect Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.1 M

Protect Pharmaceutical Technical Analysis

Protect Pharmaceutical's future price can be derived by breaking down and analyzing its technical indicators over time. Protect Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Protect Pharmaceutical. In general, you should focus on analyzing Protect Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Protect Pharmaceutical Predictive Forecast Models

Protect Pharmaceutical's time-series forecasting models is one of many Protect Pharmaceutical's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Protect Pharmaceutical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Protect Pharmaceutical

Checking the ongoing alerts about Protect Pharmaceutical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Protect Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Protect Pharmaceutical generated a negative expected return over the last 90 days
Protect Pharmaceutical has high historical volatility and very poor performance
Protect Pharmaceutical has some characteristics of a very speculative penny stock
Protect Pharmaceutical currently holds 101 K in liabilities. Protect Pharmaceutical has a current ratio of 0.39, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Protect Pharmaceutical until it has trouble settling it off, either with new capital or with free cash flow. So, Protect Pharmaceutical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Protect Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Protect to invest in growth at high rates of return. When we think about Protect Pharmaceutical's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (122.61 K) with profit before overhead, payroll, taxes, and interest of 0.
About 84.0% of the company outstanding shares are owned by corporate insiders

Additional Tools for Protect Pink Sheet Analysis

When running Protect Pharmaceutical's price analysis, check to measure Protect Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protect Pharmaceutical is operating at the current time. Most of Protect Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Protect Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protect Pharmaceutical's price. Additionally, you may evaluate how the addition of Protect Pharmaceutical to your portfolios can decrease your overall portfolio volatility.